DENTSPLY SIRONA (NASDAQ:XRAY) Given “Buy” Rating at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “buy” rating restated by Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. They currently have a $25.00 target price on the medical instruments supplier’s stock. Needham & Company LLC’s target price suggests a potential upside of 36.43% from the company’s current price.

Other equities analysts have also issued research reports about the company. UBS Group cut their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Mizuho began coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research cut their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Finally, Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Nine analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $26.33.

DENTSPLY SIRONA Trading Down 0.7 %

Shares of XRAY traded down $0.14 during trading hours on Tuesday, hitting $18.33. 511,507 shares of the stock traded hands, compared to its average volume of 2,262,461. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $34.91. The firm has a market capitalization of $3.64 billion, a PE ratio of -8.86, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. The business has a fifty day moving average of $19.09 and a 200-day moving average of $22.13.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Quantbot Technologies LP raised its position in DENTSPLY SIRONA by 852.6% in the 4th quarter. Quantbot Technologies LP now owns 272,849 shares of the medical instruments supplier’s stock valued at $5,179,000 after buying an additional 244,205 shares during the last quarter. Sciencast Management LP raised its position in DENTSPLY SIRONA by 236.3% in the 4th quarter. Sciencast Management LP now owns 69,276 shares of the medical instruments supplier’s stock valued at $1,315,000 after buying an additional 48,676 shares during the last quarter. Xponance Inc. raised its position in DENTSPLY SIRONA by 7.3% in the 4th quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier’s stock valued at $627,000 after buying an additional 2,235 shares during the last quarter. Counterpoint Mutual Funds LLC acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at approximately $299,000. Finally, Signaturefd LLC increased its position in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock worth $84,000 after purchasing an additional 3,706 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.